Ala-hist Ir Tablet
Product Images NDC 50991-783

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ala-hist Ir (NDC 50991-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Poly Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label2 (Alahisir2)

Drug Facts label for ALA-HIST IR 2 mg tablets containing Dexbrompheniramine Maleate. It includes active ingredients/purpose, uses, warnings, directions for adults and children, other information on storage and appearance, inactive ingredients, and a contact number for questions or comments. The label emphasizes typical antihistamine uses and safety precautions.*

FDA Label Image

Label (Alahistir)

Packaging label for ALA-HIST IR 2 mg tablets, an oral antihistamine containing Dexbrompheniramine Maleate. The label indicates a total of 60 tablets per package, manufactured by Poly Pharmaceuticals, Inc. in Huntsville, AL. Storage instructions note controlled room temperature between 15°-30°C (59°-86°F). The label includes a barcode and tamper-evident foil seal warning.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.